Liquidia Corp
LQDA- 交易所
- Nasdaq
- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001819576
近 90 天,Liquidia Corp 內部人申報 0 筆公開市場買進、15 筆賣出;2026 年第 3 季末有 306 家機構在 13F 申報持有,市值合計 $23.0 億;沒有大師持有。
持有 LQDA 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Liquidia Corp 5% 以上的持有人,依持股比例由大到小;變化是跟這位持有人的上一份申報比。
| 持有人 | 最新表單 | 持股 | 變化 | 首次申報 | 最新申報 | 原文 |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 11.90%股數 1,055 萬 | – | 2024/10/183 份 | 2026/7/8 | SEC |
| Farallon Capital Partners, L.P. | 13G/A | 9.90%股數 865.6 萬 | −0.05 個百分點原本 9.95% | 2025/7/113 份 | 2026/2/9 | SEC |
| Farallon Capital Management, L.L.C. | 13G/A | 9.40%股數 836.5 萬 | – | 2026/8/41 份 | 2026/8/4 | SEC |
| Manning Paul B | 13G/A | 6.50%股數 494.7 萬 | – | 2021/2/166 份 | 2026/8/14 | SEC |
| Iszo Capital LP | 13G | 5.20%股數 471.3 萬 | 新申報 | 2026/11/191 份 | 2026/11/19 | SEC |
持股是每位持有人最新一份申報的數字。最後一份是舊格式(2024 年 12 月 18 日以前)的持有人沒有持股比例紀錄,不列在這裡;公司被收購或下市之後,持有人通常就不再申報。
13D 與 13G 申報
Liquidia Corp 的 32 份 Schedule 13D、13G 申報,由新到舊,包括沒有持股比例的舊格式申報。
| 申報時間(美東) | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2026/11/1915:56 ET | Iszo Capital LP等 4 位 | 13G | 5.20%股數 471.3 萬 | 新申報 | 2026/11/12 | SEC |
| 2026/8/1419:39 ET | Manning Paul B等 3 位 | 13G/A | 6.50%股數 494.7 萬 | – | 2026/6/30 | SEC |
| 2026/8/408:32 ET | Farallon Capital Management, L.L.C.等 29 位 | 13G/A | 9.40%股數 836.5 萬 | – | 2026/6/30 | SEC |
| 2026/7/811:12 ET | BlackRock, Inc. | 13G/A | 11.90%股數 1,055 萬 | – | 2026/6/30 | SEC |
| 2026/2/908:56 ET | Farallon Capital Partners, L.P.等 31 位 | 13G/A | 9.90%股數 865.6 萬 | −0.05 個百分點原本 9.95% | 2025/12/31 | SEC |
| 2025/11/1212:15 ET | Farallon Capital Partners, L.P.等 30 位 | 13G/A | 9.95%股數 856.6 萬 | +1.95 個百分點原本 8.00% | 2025/9/30 | SEC |
| 2025/7/1118:32 ET | Farallon Capital Partners, L.P.等 30 位 | 13G | 8.00%股數 683.2 萬 | 新申報 | 2025/7/7 | SEC |
| 2025/2/1217:34 ET | Legend Aggregator, LP等 2 位 | 13G/A | 2.20%股數 186.0 萬 | –低於 5% | 2024/12/31 | SEC |
| 2024/11/12 | Manning Paul B | 13G/A舊制 | – | – | – | SEC |
| 2024/11/8 | BlackRock, Inc. | 13G舊制 | – | – | – | SEC |
| 2024/10/18 | BlackRock, Inc. | 13G舊制 | – | 新申報 | – | SEC |
| 2024/9/12 | Caligan Partners LP | 13D/A舊制 | – | – | – | SEC |
| 2024/9/4 | Caligan Partners LP | 13D/A舊制 | – | – | – | SEC |
| 2024/2/14 | Manning Paul B | 13G/A舊制 | – | – | – | SEC |
| 2024/2/717:09 ET | BlackRock Inc. | 13G/A舊制 | – | – | – | SEC |
| 2024/1/3114:08 ET | BlackRock Inc. | 13G舊制 | – | – | – | SEC |
| 2024/1/16 | Legend Aggregator, LP | 13G舊制 | – | 新申報 | – | SEC |
| 2023/12/14 | Caligan Partners LP | 13D/A舊制 | – | – | – | SEC |
| 2023/5/511:52 ET | BlackRock Inc. | 13G舊制 | – | – | – | SEC |
| 2023/2/14 | Manning Paul B | 13G/A舊制 | – | – | – | SEC |
| 2023/2/1309:25 ET | BlackRock Inc. | 13G舊制 | – | 新申報 | – | SEC |
| 2023/2/1 | Canaan VIII LP | 13G/A舊制 | – | – | – | SEC |
| 2022/2/14 | Manning Paul B | 13G/A舊制 | – | – | – | SEC |
| 2022/1/5 | New Enterprise Associates 12, Limited Partnership | 13D/A舊制 | – | – | – | SEC |
| 2021/12/7 | Caligan Partners LP | 13D/A舊制 | – | – | – | SEC |
| 2021/4/15 | Caligan Partners LP | 13D舊制 | – | 新申報 | – | SEC |
| 2021/2/16 | Manning Paul B | 13G舊制 | – | 新申報 | – | SEC |
| 2021/2/11 | Xeraya LT Ltd | 13G/A舊制 | – | – | – | SEC |
| 2021/2/5 | Eshelman Ventures, LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/2/3 | Canaan VIII LP | 13G/A舊制 | – | – | – | SEC |
| 2021/1/28 | Eshelman Ventures, LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/1/22 | Eshelman Ventures, LLC | 13G/A舊制 | – | – | – | SEC |
Form 144:內部人預計賣出
高階主管、董事與其他關係人預計賣出 Liquidia Corp 股票的 45 份通知,由新到舊。
| 申報時間(美東) | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2026/9/1416:11 ET | Ramandeep Singh董事 | 8,468 | $56.0 萬 | 2026/9/14 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/9/1117:17 ET | Ramandeep Singh董事 | 9,024 | $61.9 萬 | 2026/9/11 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/8/2116:37 ET | Jason Adair高階主管 | 7.36 萬 | $523.1 萬 | 2026/8/2110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/8/1916:26 ET | Katherine T. Rielly-Gauvin董事 | 5.52 萬 | $410.2 萬 | 2026/8/1910b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/8/1916:04 ET | Rajeev Saggar高階主管 | 5.00 萬 | $370.3 萬 | 2026/8/19 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/8/1717:01 ET | Rajeev Saggar高階主管 | 2.95 萬 | $226.9 萬 | 2026/8/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/1116:26 ET | Sarah Krepp高階主管 | 2.49 萬 | $162.3 萬 | 2026/6/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/1016:52 ET | Canaan VIII LP董事 | 20.0 萬 | $1,300 萬 | 2026/6/10 | UBS Financial Services Inc | SEC |
| 2026/6/816:11 ET | Canaan VIII LP董事 | 20.0 萬 | $1,280 萬 | 2026/6/8 | UBS Financial Services Inc | SEC |
| 2026/6/418:38 ET | Paul B Manning董事 | 20.0 萬 | $1,114 萬 | 2026/6/4 | Fidelity Brokerage Services LLC | SEC |
| 2026/6/417:24 ET | Canaan VIII LP董事 | 20.0 萬 | $1,300 萬 | 2026/6/4 | UBS Financial Services Inc | SEC |
| 2026/6/109:56 ET | Kirsch Arthur S董事 | 3.00 萬 | $184.1 萬 | 2026/6/1 | Fidelity Brokerage Services LLC | SEC |
| 2026/5/2117:12 ET | Ramandeep Singh董事 | 2.95 萬 | $177.3 萬 | 2026/5/21 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/5/2016:37 ET | Serendipity Biopharma LLC董事 · 高階主管 | 10.6 萬 | $638.4 萬 | 2026/5/2010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/5/1416:26 ET | Serendipity Biopharma LLC董事 · 高階主管 | 10.0 萬 | $575.9 萬 | 2026/5/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/5/1117:52 ET | Canaan VIII LP董事 | 31.9 萬 | $1,590 萬 | 2026/5/11 | UBS Financial Services Inc | SEC |
| 2026/5/816:19 ET | Serendipity Biopharma LLC董事 · 高階主管 | 10.0 萬 | $422.8 萬 | 2026/5/810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/5/716:18 ET | Serendipity Biopharma LLC董事 · 高階主管 | 2.50 萬 | $105.3 萬 | 2026/5/710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1716:39 ET | Serendipity Biopharma LLC董事 · 高階主管 | 6.88 萬 | $285.0 萬 | 2026/4/1710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1616:13 ET | Serendipity Biopharma LLC董事 · 高階主管 | 2.50 萬 | $100.3 萬 | 2026/4/1610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1516:43 ET | Serendipity Biopharma LLC董事 · 高階主管 | 2.47 萬 | $95.7 萬 | 2026/4/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1516:42 ET | Michael Kaseta高階主管 | 13.9 萬 | $539.6 萬 | 2026/4/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1416:37 ET | Michael Kaseta高階主管 | 3,000 | $11.7 萬 | 2026/4/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1016:35 ET | Serendipity Biopharma LLC董事 · 高階主管 | 2.50 萬 | $100.8 萬 | 2026/4/1010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1016:34 ET | Michael Kaseta高階主管 | 2.38 萬 | $96.0 萬 | 2026/4/1010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
只列最新的 25 份。看 LQDA 近 12 個月的全部通知